Condition: Bone Lesion · Sponsor: Central Hospital, Nancy, France
The hypothesis of the study is that non-invasive Single photon emission computed tomography (SPECT-CT) bone scintigraphy makes it possible to better characterize solitary bone lesions, in particular the exclusion of their malignancy in order to avoid unnecessary biopsy and possible complications for the patient.
This description comes directly from the study's public registry record.
ACHRAF BAHLOUL, MD, MSc · 383154003 · a.bahloul@chru-nancy.fr
VERONIQUE ROCH, MSc · 383154276 · v.roch@chru-nancy.fr
Always discuss trial participation with your own doctor first.
| CHRU Nancy | Vandœuvre-lès-Nancy, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05934994